Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Vycor Medical (VYCO) Shares Outstanding (2016 - 2025)

Vycor Medical has reported Shares Outstanding over the past 15 years, most recently at $270306.0 for Q4 2025.

  • Quarterly Shares Outstanding fell 99.19% to $270306.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $270306.0 through Dec 2025, down 99.19% year-over-year, with the annual reading at $270306.0 for FY2025, 99.19% down from the prior year.
  • Shares Outstanding was $33.5 million for Q4 2025 at Vycor Medical, roughly flat from $33.5 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $33.5 million in Q4 2024 and troughed at -$103334.0 in Q4 2021.
  • The 5-year median for Shares Outstanding is $270306.0 (2021), against an average of $10.0 million.
  • The largest YoY upside for Shares Outstanding was 27030500.0% in 2021 against a maximum downside of 100.38% in 2021.
  • A 5-year view of Shares Outstanding shows it stood at -$103334.0 in 2021, then skyrocketed by 31677.71% to $32.6 million in 2022, then plummeted by 99.17% to $270306.0 in 2023, then soared by 12246.3% to $33.4 million in 2024, then plummeted by 99.19% to $270306.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Shares Outstanding are $270306.0 (Q4 2025), $1.0 (Q3 2025), and $270306.0 (Q2 2025).